ASPIRE Participant Information Sheet
A copy of the Australian Particle Therapy Clinical Quality Registry – ASPIRE participant information sheet can be viewed via this link:
ASPIRE – Patient Information Sheet
ASPIRE 2022/2023 First Yearly Report
A copy of the Australian Particle Therapy Clinical Quality Registry – ASPIRE first year report can be viewed via this link:
Australian New Zealand Clinical Trials Registry
The Australian Particle Therapy Clinical Quality Registry – ASPIRE is registered with the Australian New Zealand Clinical Trials Registry (ANZCTR).
The ANZCTR is recognised as an international committee of Medical Journal Editors acceptable registry and a Primary Registry in the World Health Organisation (WHO) registry network.
Additional information on the Australian Particle Therapy Clinical Quality Registry – ASPIRE can be found on the following link➡️ ANZCTR – Registration
TROG Cancer Research
Trans-Tasman Radiation Oncology Group – TROG Cancer Research, is dedicated to improving the way radiation therapy is delivered to cancer patients with ongoing scientific research, clinical trials, and cutting-edge technology.
TROG Cancer Research are proud collaborators of the Australian Bragg Centre for Proton Therapy and Research and have officially endorsed the Australian Particle Therapy Clinical Quality Registry – ASPIRE.
Learn more about the great work being done by TROG Cancer Research on their website ➡️ https://trog.com.au/
The Hospital Research Foundation Group
The Hospital Research Foundation Group provides grants for vital medical research, equipment and patient care projects across all public hospitals, universities and medical research centres in South Australia.
The Australian Particle Therapy Clinical Quality Registry is proudly supported by grant funding from the Hospital Research Foundation Group.
More information about this amazing foundation can be found on their website: https://hospitalresearch.org.au/